Mesothelioma attorneys at Pintas & Mullins Law Firm highlight a new study recently published in the Journal of Thoracic and Cardiovascular Surgery examining the speed of tumor growth in mesothelioma patients after the first resection surgery and how it affected the second surgery’s outcome. The study was conducted by researchers at Stanford University. For patients with malignant pleural …
New Diagnostic Tests for Mesothelioma Involves Little Pain or Risk
Mesothelioma lawyers at Pintas & Mullins Law Firm highlight recent research which found promising results from a new diagnostic test for peritoneal mesothelioma. The biopsy test uses a small needle and single skin puncture to diagnose the abdominal disease. There are three main types of mesothelioma: pleural, which refers to cancer of the lining of the …
Immunotherapy Treatment Shows Promise in Mesothelioma Patients
Mesothelioma attorneys at Pintas & Mullins Law Firm always keep a watchful eye out for new, progressing or breakthrough clinical trials aimed at mesothelioma treatment and therapy. Results from one of the latest trials in this field is for a new immunologic antibody, known as tremelimumab, and was recently published in The Lancet Oncology. Tremelimumab is a monoclonal antibody …
$1.3 Million Award for Family of Mesothelioma Victim
Mesothelioma lawyers at Pintas & Mullins Law Firm report that a Pennsylvania court recently upheld a $1.3 million verdict in favor of the estate of a welder and custodian at a metal fabrication plant, Hobart Brothers Co. Hobart attempted to have the case thrown out based on the testimony of a doctor preempted by a 2012 …
Wife of Welder Files Mesothelioma Wrongful Death Lawsuit
Asbestos exposure attorneys at Pintas & Mullins Law Firm report that the Arizona Supreme Court recently ruled that New Mexico law does apply to a wrongful death lawsuit filed by the wife of a welder who was exposed to asbestos on the job and consequently died of mesothelioma. The man, Dudley Pounders, was living in Arizona …
$6 Million Verdict in Mesothelioma Case against Dow Chemical
Mesothelioma attorneys at Pintas & Mullins Law Firm report that a Louisiana jury recently awarded a mesothelioma patient $5.95 million in damages. The plaintiff sued Dow Chemical for knowingly exposing him to asbestos, thereby causing his cancer development. Sidney Mabile was exposed to asbestos at the Plaquemine Dow Chemical plant when he worked there as an …
Human Mesothelioma Trials to Begin for New Genetic Drug
Mesothelioma attorneys at Pintas & Mullins Law Firm announce that researchers at the Asbestos Diseases Research Institute (ADRI) are prepping to begin a clinical trial for a new drug therapy for mesothelioma. The trial comes after a three-year study to characterize the gene expression in mesothelioma. Research teams at ADRI ultimately found that a specific family …
Medical Scientists Test Mesothelioma Skin Cream Drug
Mesothelioma lawyers at Pintas & Mullins Law Firm report that scientists at the Griffith University School of medical Science are looking into a new drug applied to the skin in a cream-like form and targets cancerous mesothelioma cells. The new drug would enter the blood stream through the skin, target and infiltrate cancer cells to try …
Acupuncture May Reduce Symptoms of Mesothelioma
Mesothelioma lawyers at Pintas & Mullins Law Firm report on a recent study published in the medical journal Current Oncology that evaluated the effects of acupuncture on mesothelioma symptom relief. The study, which included over 30 patients, found statistically significant improvements in pain, nausea, appetites, nervousness, and general well-being. These five symptoms are the most commonly reported symptoms …
CDC Admits Polio Vaccine May have been Contaminated with Cancer Virus
The U.S. Centers for Disease Control and Prevention (CDC) recently published a fact sheet on its website, which it also quickly removed, outlining the contamination of the polio vaccine with a known cancer virus, SV40. SV40 (Simian virus 40) is a polyomavirus found in some species of monkey, and was discovered in 1960. Soon after …
Verastem to Begin Mesothelioma Clinical Trials
Mesothelioma lawyers at Pintas & Mullins Law Firm report that Verastem, during its most recent Research and Development Day, announced that its new drug to treat mesothelioma will be ready to begin clinical trials by the third quarter of 2013. Members of Verastem’s leadership team gave an overview of the new development program in New York …
EnPro Industries Estimates Liability for Mesothelioma Claims
Mesothelioma attorneys at Pintas & Mullins Law Firm announce that Garlock Sealing Technologies, a subsidiary of EnPro Industries, recently filed a pre-trial brief for its upcoming trial to determine liability for pending and future mesothelioma claims. One expert estimates the liability to be around $125 million. This is about half the amount Garlock Sealing Technologies (GST) …
New Mesothelioma Drug to Begin Enrolling Trial Participants
Mesothelioma attorneys at Pintas & Mullins Law Firm are happy to announce that Verastem, a cancer drug development company, recently held a mesothelioma briefing session at the annual American Society of Clinical Oncology in Chicago. The company announced that its lead compound recently received allowance from the FDA to begin clinical trials. The company will begin …
Researchers Develop “Inhaled” Chemotherapy Treatment
Mesothelioma attorneys at Pintas & Mullins Law Firm highlight a recent breakthrough by researchers at several prominent cancer institutes, promising a new drug delivery system that will allow lung cancer patients to inhale chemotherapeutic drugs. The developments were made by researchers at Oregon State University, Rutgers University, and the Cancer Institute of New Jersey, and recently …
Research Reveals Cancer-Suppressing Protein
Mesothelioma lawyers at Pintas & Mullins Law Firm report of a recent breakthrough by researchers at the Walter and Eliza Hall Institute involving a powerful protein called p53. More than half of human cancers, including mesothelioma, are associated with defects in the gene for p53. The Australian researchers dissected the processes that are controlled by p53 …
New Treatment Options for Mesothelioma Patients
Mesothelioma attorneys at Pintas & Mullins Law Firm report of two recent discoveries in cancer immunotherapy and gene therapy treatments. The first breakthrough comes from the H. Lee Moffitt Cancer Center in Florida, focusing on a drug affecting the immune system. The second was discovered by researchers at South Paris University involving a new drug for …
Noninvasive Test for Early Mesothelioma Detection Introduced
Mesothelioma lawyers at Pintas & Mullins Law Firm highlight a new peer-reviewed study recently published in PLOS ONE. Researchers aimed to find a new and efficient noninvasive surveillance tool to help catch mesothelioma in its earliest stages. Researchers conducted the case-controlled studies in numerous health care centers, collecting serum from 117 patients with malignant pleural mesothelioma …
First Mesothelioma Patient Undergoes Robot-Assisted Surgery
Mesothelioma lawyers at Pintas & Mullins Law Firm report that a doctor at the University of Arizona Medical Center recently performed the first-and second-ever robot-assisted extrapleural pneumonectomy on two mesothelioma patients. The doctor used the new da Vinci Surgical System, a controversial new technology in the highly complex procedures. An extrapleural pneumonectomy (EPP) is one of two …
Minnesota Taconite Workers Mesothelioma Study
Mesothelioma attorneys at Pintas & Mullins Law Firm highlight an extensive study recently conducted by the University of Minnesota that studied the significant ailing of mesothelioma in Iron Range taconite workers. In 2007 it was made public that mesothelioma was striking these miners at twice the average rates, and the new study attempted to find the …
New Biosensor to Detect Mesothelioma
Mesothelioma lawyers announce that researchers at NYU recently developed a biosensor and method to detect pleural mesothelioma. A protein referred to as HAPLN1 is significantly over-expressed in mesothelioma patients, and scientists recently discovered new ways to detect this protein in the blood serum of high-risk patients. Mesothelioma, more than almost any other type of cancer, is …